Investors and Media

Press Releases

November 14, 2022

Scholar Rock Reports Third Quarter 2022 Financial Results and Highlights Business Progress

November 10, 2022

Recent Phase 1 DRAGON Data Show SRK-181 Continues to be Well Tolerated with Early Indications of Efficacy

November 9, 2022

Scholar Rock Appoints Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer

November 8, 2022

Scholar Rock to Participate in Upcoming Investor Conferences

October 22, 2022

New Phase 2 TOPAZ Trial Data Indicate Positive Trends in Quality-of-Life Measures Over 24 Months with Apitegromab for Nonambulatory Patients with Types 2 and 3 SMA

October 6, 2022

Scholar Rock to Present Data from the Phase 1 DRAGON trial at the SITC 37th Annual Meeting

October 4, 2022

Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy

September 22, 2022

Scholar Rock Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Archived Press Releases